IPOS trademark

INBRIJA

Under examinationIPOSWord markClass 5Class 10

"INBRIJA" is a word mark owned by Merz Pharmaceuticals, LLC, filed at the IPOS on September 22, 2026. It is under examination and covers classes 5 and 10.

Get this data via the API
Official IPOS record
INBRIJA trademark as filed
As filed with the IPOS
Status
Under examination
Since September 22, 2026
Filed
September 22, 2026
Registered
Not yet
Expires
Not recorded
Application no.
40202625503P
Registration no.
Not yet
Office
IPOS
Intellectual Property Office of Singapore
Mark type
Word mark
2 classes
Ownership

Who owns INBRIJA

The owner and representative on file with the office.

Owner

Merz Pharmaceuticals, LLC

United States

Representative

Spruson & Ferguson (Asia) Pte. Ltd.

Spruson & Ferguson (Asia) Pte. Ltd.

Goods and services

What the mark covers

The products and services INBRIJA is filed for, grouped by Nice class.

  • Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system

  • Inhalation devices, that facilitate delivery of pharmaceutical products for treating diseases, disorders or conditions of the human central nervous system including Parkinson's disease

History

What has happened so far

Steps recorded by the IPOS, newest first.

  1. Application filed
FAQ

About INBRIJA

Who owns the trademark "INBRIJA"?

The IPOS trademark "INBRIJA" (application 40202625503P) is owned by Merz Pharmaceuticals, LLC.

What is the status of "INBRIJA"?

Its status at the IPOS is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull INBRIJA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0cc72-b644-723d-9636-431b29d5a2cf
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0cc72-b644-723d-9636-431b29d5a2cf",
  "object": "trademark",
  "mark_text": "INBRIJA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "SG",
  "application_number": "40202625503P",
  "filing_date": "2026-09-22",
  "nice_classes": [
    5,
    10
  ],
  "owners": [
    {
      "name": "Merz Pharmaceuticals, LLC",
      "entity_id": null
    }
  ]
}